Navigation Links
Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Date:10/1/2009

CAMBRIDGE, Mass., Oct. 1 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that two abstracts on IDX184, the company's lead hepatitis C development program, have been accepted for presentation at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD, October 30-November 3, 2009 in Boston, Massachusetts). Full abstracts can now be viewed at the AASLD website at www.aasld.org.

The accepted abstracts are as follows:

  • Lalezari, et al, "Antiviral Activity, Safety and Pharmacokinetics of IDX184, A Liver-Targeted Nucleotide HCV Polymerase Inhibitor, in Patients with Chronic Hepatitis C", will be presented in a late-breaking poster session on Monday, November 2 between 8:00 a.m. - 5:30 p.m.
  • Lallos, et al, "Combination of IDX184, a Nucleotide Prodrug Polymerase Inhibitor, With Other Classes of HCV Inhibitors is Additive to Synergistic in the HCV Replicon In Vitro" will be presented in a poster session entitled HCV Therapy: Preclinical and Clinical Development on Tuesday, November 3, 2009 between 8:00 a.m. - 1:00 p.m.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of infections caused by hepatitis C virus. For further information about Idenix, please refer to

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
2. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
3. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
4. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
5. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
9. Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
10. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
11. Idenix to Host Conference Call Discussing Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... iLab Solutions, the leader in core facility management ... Product Strategy. In this role, Michelle will work with current ... in the development of iLab products. Her main goal will ... to the scientific community by offering the most advanced, user-friendly, ...
(Date:1/14/2014)... Rockville, MD (PRWEB) January 14, 2014 ... dedicated to developing innovative information technology solutions for ... other health care stakeholders, announced today the signing ... the US Food and Drug Administration (FDA). ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Kerr Corporation, a ... video and additional how-to information about dual arch impressions on ... with Dual Arch Impressions,” the blog entry serves up a ... and houses a step-by-step demonstration by Dr. David Little as ...
(Date:1/14/2014)... January 14, 2014 BioMedomics, Inc. , ... POC diagnostic platforms and novel disease specific POC tests, announced ... financing netting a total of $690,000. The investment is from ... the company. This group of private investors has significant successful ...
Breaking Biology Technology:iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2BioMedomics, Inc. Closes $690K Round of Financing 2
... Pursues Additional Approvals Globally for Dialysis and Earlier Stage ... Chronic Kidney ... GENZ ) today announced the U.S. launch of the ... progress in its international efforts to secure additional,approvals for the ...
... PharmAthene, Inc., a,biodefense company specializing in the ... biological threats, announced,today that it has completed the ... spectrum chemical nerve agent prophylaxis., The PK ... used the final,pegylated version of rBChE for the ...
... - Continues Consolidation of Competitors in Key Markets ... China Nepstar,Chain Drugstore Ltd. (NYSE: NPD ) ... in China based on the number of directly ... a definitive agreement,with DongGuan Hui Ren Tang Pharmaceutical ...
Cached Biology Technology:Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients 2Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients 3Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients 4Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients 5PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 2PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 3PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008 4China Nepstar Chain Drugstore to Acquire 18 Stores from Dongguan Hui Ren Tang Pharmaceutical Co. 2China Nepstar Chain Drugstore to Acquire 18 Stores from Dongguan Hui Ren Tang Pharmaceutical Co. 3China Nepstar Chain Drugstore to Acquire 18 Stores from Dongguan Hui Ren Tang Pharmaceutical Co. 4
(Date:4/23/2014)... researcher has shed light on how an estimated one ... outback have become reviled as pests and culled on ... and Sustainability Institute at the University of Exeter,s Penryn ... from their historic role helping to create the country,s ... , The deserts of the Australian outback are a ...
(Date:4/23/2014)... mammals, ravens form different types of social relationships ... also form strict dominance relations. From a cognitive perspective, ... ability in daily social life ("knowing who is nice ... have with each other sets the stage for "political" ... this study have been published in the scientific journal ...
(Date:4/23/2014)... a 2 million Food Standards Agency (FSA) project to ... industry workers. , Norovirus outbreaks can rapidly affect ... of frozen strawberries infected 11,000 people in Germany, but ... which strains cause infection and which foods are the ... Researchers will produce data that will help the FSA ...
Breaking Biology News(10 mins):How Australia got the hump with 1 million feral camels 2How Australia got the hump with 1 million feral camels 3Ravens understand the relations among others 2
... to promote company,s highly secure, do it ... smartTOUCH(R) finger activated products, JERICHO, N.Y., Sept. 16 ... it has hired Debbe Dunning as,the company,s new spokesperson ... advertising campaign directed at the Home Improvement,market., (Photo: ...
... 16, 2008)- A team of scientists headed by neuroscientist Dr. ... the National Institute of Health (NIH), to develop a technique that ... Chiba, a professor at the University of Miami,s Department of Biology, ... to enhance synapse formation or nerve regeneration., ...
... , Researchers at McGill University and the affiliated Lady ... with colleagues at the University of Ottawa and the Ottawa ... use of viruses to target and destroy cancer cells, a ... the September early edition of the Proceedings of the ...
Cached Biology News:'Home Improvement' Star Debbe Dunning is New smartTOUCH Spokesperson 2'Home Improvement' Star Debbe Dunning is New smartTOUCH Spokesperson 3NIH EUREKA grant awarded to University of Miami scientist 2Viral 'magic bullet' targets cancer cells with help of new compound 2
... Application: A tracking dye for ... polyacrylamide gels including DNA sequencing. Preparation ... 0.05% is recommended. A 2% stock ... 5-10 buffer. Chem comp: Dye ...
... The VSOS-4 Orbital Shaker is designed to ... provide a uniform motion that is both mixing ... VSOS-4 Orbital Shaker provides a smooth, quiet, reproducible ... a wide range of laboratory applications such as ...
... The Biometra TProfessional Thermocycler combines top performance ... block achieves high speed and unparalleled temperature ... display providing programming in a spreadsheet or ... Performance Smart Lid opens on the push ...
... The Synaptic Vesicles Isolation Kit provides ... an enriched synaptic vesicle fraction. The ... lysis of the synaptosomes, and differential ... gradient. The kit also contains an ...
Biology Products: